Physician profile
Boyd E Helm
NPI 1073514576
$3,436.11
in general payments reported to CMS, 2019-2025
24 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $496 · 2021: $395 · 2022: $600 · 2023: $691 · 2024: $335 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $811.89 | 2019-2025 | Repatha |
| Irhythm Technologies, INC. | $472.71 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $376.52 | 2019-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Pfizer INC. | $266.82 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $212.82 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $180.75 | 2022-2025 | Onpattro |
| Esperion Therapeutics, INC. | $160.91 | 2021-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $143.51 | 2019-2025 | Eliquis |
| Astrazeneca Pharmaceuticals Lp | $114.12 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $106.20 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $74.70 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.70 | 2022-2023 | Lifevest |
| Novo Nordisk INC | $53.70 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Arbor Pharmaceuticals, INC. | $50.66 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.41 | 2023-2024 | Jardiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $48.54 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $41.89 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $36.85 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $36.64 | 2023 | Inpefa |
| Medtronic, INC. | $36.41 | 2023-2025 | Symplicity G3, Evera Mri Xt Dr Surescan |
| Itamar Medical INC | $32.98 | 2025 | Watchpatone |
| Abiomed | $30.69 | 2025 | |
| Impulse Dynamics (USA) INC. | $28.30 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Helm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.